BCL2 and acute lymphoblastic leukemia: Inhibition of Pim kinases in Ph + ALL, including relapsed and refractory Ph + ALL, leads to robust reductions in colony formation, which are further enhanced with the addition of the Bcl-2 antagonist, sabutoclax [162].